PCR Machines in Texas

Ansh Labs, a VION Biosciences company based in Webster, Texas, is a specialized biotechnology firm founded in 2010 that develops, manufactures, and distributes high-quality immunodiagnostic assays, reagents, and ELISA kits for biomedical research and clinical diagnostics. The company leverages in-house antibody development and characterization capabilities to create immunoassays targeting clinically significant biomarkers. Ansh Labs offers validated ELISA immunoassays with rapid turnaround times, high specificity, and excellent sensitivity—supporting 24-month shelf lives and straightforward procedures. Core service offerings include contract development of custom immunoassays, immunoassay method development and validation, assay optimization, cross-reactivity testing, and preclinical biomarker testing. The company serves life science researchers, hospitals, commercial laboratories, and public health agencies, with particular expertise in areas such as cancer diagnostics, fertility biomarker testing, obesity research, and specialty assays for glucagon regulation and reproductive health. Following its acquisition by VION Biosciences in August 2024, Ansh Labs continues to maintain its team and product portfolio while expanding its service capabilities.

Nuclein, LLC is an in vitro diagnostics company specializing in rapid, point-of-care molecular diagnostic solutions for infectious diseases. Based in Austin, Texas and founded in 2017, the company develops portable, battery-powered PCR platforms that deliver lab-quality results in approximately 15 minutes without requiring traditional laboratory infrastructure. The flagship DASH Rapid PCR System is an FDA-cleared, CLIA-waived platform featuring an intuitive user interface, room-temperature cartridge storage, Wi-Fi and cloud connectivity, and multiplex-capable testing in a single cartridge. The system supports multiple sample types and has a compact footprint (15"D x 11"H x 4"W). Nuclein's current test menu includes the DASH SARS-CoV-2 & Flu A/B Test with dual FDA clearance, with plans to expand to additional infectious disease and condition testing. The platform is designed for healthcare settings, urgent care, clinics, and other point-of-care environments where rapid, accurate molecular diagnostics can inform immediate treatment decisions.

Bio-Rad Laboratories is a global life science and clinical diagnostics company that manufactures and distributes instruments, reagents, consumables, controls, and data management software for research and diagnostics laboratories. The company serves academic research, industrial bioprocessing, and clinical diagnostic markets with a diverse product portfolio spanning PCR and qPCR systems (including proprietary ddPCR digital droplet technology), Western blotting reagents and systems, blood typing and screening products, immunoassay controls, antibodies, cell counting equipment, gel documentation and imaging systems, and process separation solutions for biopharmaceutical purification. Bio-Rad's offerings extend to quality control solutions, specialized testing kits for oncology mutation detection and infectious disease screening, and classroom education products. The company maintains robust e-commerce capabilities including PunchOut procurement integration, quick ordering, order status tracking, and document library management for B2B customers. Product lines include the QX200/QX600 ddPCR platforms, CFX Real-Time PCR systems, TC20 automated cell counters, ChemiDoc imaging systems, and specialized molecular detection kits. Bio-Rad serves clinical laboratories, research institutions, biotech firms, and educational organizations globally with regulatory credentials supporting ISO and FDA compliance across its diagnostics and instrument portfolios.

Gene by Gene is a Houston-based CLIA-certified, CAP-accredited, and COLA-accredited clinical laboratory specializing in advanced genetic testing services. Founded in 2000, the company operates as a subsidiary of myDNA Inc. and provides a comprehensive spectrum of laboratory services including whole genome sequencing (WGS), whole exome sequencing (WES), custom targeted NGS panels, SNP array analysis, Sanger sequencing, and pharmacogenomics testing. The company serves clinical practitioners, researchers, and healthcare organizations globally with rapid turnaround times and competitive pricing. Gene by Gene's in-house laboratory features robotic automation and scalable sequencing and microarray technologies. Services extend to forensic genetics (through partnership with Verogen Inc.), paternity and relationship testing, population genetics research, and biobanking. The laboratory holds permits from multiple states including California, New York, Pennsylvania, and Maryland, and is AABB-accredited for relationship testing, ensuring exceptional result accuracy and compliance with regulatory standards.

Fort Worth Diagnostics is a cGMP-compliant assay manufacturer specializing in reagents and controls for digital PCR (dPCR) and quantitative PCR (qPCR) platforms. The company develops and manufactures bacterial, fungal, oncology, and viral controls optimized for open-system compatibility. Fort Worth Diagnostics offers both catalog and custom solutions, including probe and primer design, bioinformatics analysis, and in-process dPCR testing to ensure reproducibility. With typical turnaround times of 8 weeks for custom manufacturing and a focus on quality and customer service, the company serves molecular diagnostics laboratories, research institutions, and clinical diagnostic centers requiring validated PCR reagents and external controls.

Asuragen is a molecular diagnostics company specializing in genetic carrier screening and precision oncology testing. Founded in 2006 and acquired by Bio-Techne Corporation in 2021, the company develops advanced diagnostic solutions utilizing proprietary chemistries and miRNA-based technologies. Their product portfolio includes genetic testing kits for inherited disorders (Fragile X, CFTR, SMN1/2, HTT), precision oncology solutions for chronic myeloid leukemia (CML) and solid tumor monitoring, custom molecular quality controls, and armored RNA controls. The AmplideX product line encompasses PCR/CE-based assays optimized for clinical laboratories. Asuragen operates a GMP-compliant manufacturing facility and CLIA-certified laboratory, serving clinical diagnostics and research applications across oncology, genetic disorders, and carrier screening markets. The company maintains strategic partnerships and distributes products across North America and EMEA regions.